Delivery by Caesarean section and infant cardiometabolic status at one year of age

Jenna Haji1, Jill K Hamilton2, Chang Ye1

  • 1Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto ON.

Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|November 7, 2014
PubMed

Insights

Caesarean section delivery did not impact infant cardiometabolic risk factors at one year. However, delivery method may influence maternal-infant associations for certain metabolic markers.

Area of Science:

  • Neonatal health
  • Maternal health
  • Metabolic disease research

Background:

  • Gut microbiome disruption is linked to obesity, insulin resistance, and type 2 diabetes.
  • Caesarean section (CS) may disrupt the neonatal gut microbiome, raising concerns about early-life cardiometabolic health.
  • Investigating the long-term effects of delivery mode on infant health is crucial.

Purpose of the Study:

  • To compare the cardiometabolic status of infants delivered by Caesarean section (CS) versus vaginally.
  • To assess potential early-life adverse health outcomes associated with CS delivery.
  • To understand the influence of delivery mode on infant metabolic profiles.

Main Methods:

  • Prospective observational cohort study involving 104 women.
  • Cardiometabolic evaluation of mothers during pregnancy and infants at one year of age.
  • Infant assessment included anthropometry and measurement of cardiometabolic risk variables.

Main Results:

  • No significant differences in mean BMI, skinfold sum, fasting glucose, insulin resistance, or lipid profiles between CS and vaginally delivered infants at one year.
  • No differences in C-reactive protein, leptin, or adiponectin levels between the two groups after covariate adjustment.
  • Maternal-infant associations for adiponectin and lipids were noted in the vaginal delivery group, while leptin association was specific to the CS group.

Conclusions:

  • Caesarean section delivery was not associated with an adverse infant cardiometabolic risk profile at one year of age.
  • Delivery mode may influence how maternal factors impact infant cardiometabolic risk.
  • Further research is needed to elucidate the long-term cardiometabolic implications of CS delivery.
Abstract

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
48
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.7K
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
5.1K